enteca film coated tablet 0.5mg
ranbaxy (malaysia) sdn. bhd. - entecavir monohydrate eqv. entecavir - tablet, film coated - entecavir monohydrate eqv. entecavir 0.5mg
enteca film-coated tablet 1mg
ranbaxy (malaysia) sdn. bhd. - entecavir monohydrate eqv. entecavir - tablet, film coated - entecavir monohydrate eqv. entecavir 1mg
entecavir dr.reddy’s 0.5 mg film-coated tablets
reddy pharma iberia s.a. avinguda de josep tarradellas 38 barcelona, 08029, spain - film-coated tablet - entecavir 0.5 mg - antivirals for systemic use
entecavir rowex 0.5 mg film-coated tablets
rowex ltd - entecavir monohydrate - film-coated tablet - 0.5 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir
entecavir rowex 1 mg film-coated tablets
rowex ltd - entecavir monohydrate - film-coated tablet - 1 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir
entecavir teva 0.5 mg film-coated tablets
teva b.v. - entecavir - tablet - 0.5 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir
entecavir 0.5 mg film-coated tablet
accord healthcare ireland ltd. - entecavir monohydrate - film-coated tablet - 0.5 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir
entecavir 1 mg film-coated tablet
accord healthcare ireland ltd. - entecavir monohydrate - film-coated tablet - 1 milligram(s) - nucleoside and nucleotide reverse transcriptase inhibitors; entecavir
baraclude 1 mg
bristol, myers squibb (israel) limited - entecavir 1 mg - film coated tablets - entecavir - baraclude is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. this indication is based on clinical trial data in patients with hbeag positive and hbeag negative hbv infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis b.decompensated liver disease.
baraclude oral solution 0.05mg/ml
bristol-myers squibb (singapore) pte. ltd. - entecavir - solution - 0.05mg/ml